MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4

BACKGROUND: Aim to determine the clinicopathological and prognostic role of miR-301a-3p in pancreatic ductal adenocarcinoma(PDAC), to investigate the biological mechanism of miR-301a-3p in vitro and in vivo. METHODS: By tissue microarray analysis, we studied miR-301a-3p expression in PDAC patients a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Xia, Xiang, Zhang, Kundong, Cen, Gang, Jiang, Tao, Cao, Jun, Huang, Kejian, Huang, Chen, Zhao, Qian, Qiu, Zhengjun
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673249/
https://ncbi.nlm.nih.gov/pubmed/26019136
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items